A Treatment to Cure Diabetes Using Plant-Based Drug Discovery
The field of peptides and proteins has opened up new doors for plant-based medication development because of analytical breakthroughs. Enzymatic breakdown of plant-specific proteins yields bioactive peptides. These plant-based proteins and peptides, in addition to their in vitro and vivo outcomes fo...
Gespeichert in:
| Veröffentlicht in: | Evidence-based complementary and alternative medicine 2022-05, Vol.2022, p.8621665-12 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 12 |
|---|---|
| container_issue | |
| container_start_page | 8621665 |
| container_title | Evidence-based complementary and alternative medicine |
| container_volume | 2022 |
| creator | Mahankali, Sumalatha Kalava, Jagadish Garapati, Yugandhar Domathoti, Bullarao Maddumala, Venkata rao Sundramurty, Venkatesa Prabhu |
| description | The field of peptides and proteins has opened up new doors for plant-based medication development because of analytical breakthroughs. Enzymatic breakdown of plant-specific proteins yields bioactive peptides. These plant-based proteins and peptides, in addition to their in vitro and vivo outcomes for diabetes treatment, are discussed in this study. The secondary metabolites of vegetation can interfere with the extraction, separation, characterization, and commercialization of plant proteins through the pharmaceutical industry. Glucose-lowering diabetic peptides are a hot commodity. For a wide range of illnesses, bioactive peptides from flora can offer up new avenues for the development of cost-effective therapy options. |
| doi_str_mv | 10.1155/2022/8621665 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9110154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2666908055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-89347d29127c6905ac65b3ec37e0b9551c668c032f1569805ec896e441565e363</originalsourceid><addsrcrecordid>eNp9kU1LAzEYhIMoVqs3z7LgRdC1SXbzdVCorV9Q0EML3kI2fdtuaXdrslvpvzeltagHT0mYh8kMg9AZwTeEMNaimNKW5JRwzvbQEREpiVMq5f7uLt4b6Nj7KcZUCSEOUSNhTHIu-RG6bUd9B6aaQ1FFVRl1agdRNzcZVOCjgc-LcfQ2M0UV3xsPw6jr6nHQvS2X4FYn6GBkZh5Ot2cTDR4f-p3nuPf69NJp92KbCFnFUiWpGFJFqLBcYWYsZ1kCQQScKcaIDWEsTuiIMK4kZmCl4pCm4ckg4UkT3W18F3U2h6ENYZ2Z6YXL58atdGly_Vsp8okel0utCMGEpcHgcmvgyo8afKXnoQPMQjMoa68p5yFY-JkF9OIPOi1rV4R6a0pwKrBKAnW9oawrvXcw2oUhWK930etd9HaXgJ__LLCDv4cIwNUGmOTF0Hzm_9t9AV4Rklw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2667627093</pqid></control><display><type>article</type><title>A Treatment to Cure Diabetes Using Plant-Based Drug Discovery</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Mahankali, Sumalatha ; Kalava, Jagadish ; Garapati, Yugandhar ; Domathoti, Bullarao ; Maddumala, Venkata rao ; Sundramurty, Venkatesa Prabhu</creator><contributor>Roy, Arpita ; Arpita Roy</contributor><creatorcontrib>Mahankali, Sumalatha ; Kalava, Jagadish ; Garapati, Yugandhar ; Domathoti, Bullarao ; Maddumala, Venkata rao ; Sundramurty, Venkatesa Prabhu ; Roy, Arpita ; Arpita Roy</creatorcontrib><description>The field of peptides and proteins has opened up new doors for plant-based medication development because of analytical breakthroughs. Enzymatic breakdown of plant-specific proteins yields bioactive peptides. These plant-based proteins and peptides, in addition to their in vitro and vivo outcomes for diabetes treatment, are discussed in this study. The secondary metabolites of vegetation can interfere with the extraction, separation, characterization, and commercialization of plant proteins through the pharmaceutical industry. Glucose-lowering diabetic peptides are a hot commodity. For a wide range of illnesses, bioactive peptides from flora can offer up new avenues for the development of cost-effective therapy options.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2022/8621665</identifier><identifier>PMID: 35586686</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Amino acids ; Diabetes ; Diabetes mellitus ; Disease ; Drug development ; Hypertension ; Insulin resistance ; Metabolites ; Peptides ; Pharmaceutical industry ; Proteins ; Secondary metabolites ; Seeds ; Signal transduction ; Sports injuries</subject><ispartof>Evidence-based complementary and alternative medicine, 2022-05, Vol.2022, p.8621665-12</ispartof><rights>Copyright © 2022 Sumalatha Mahankali et al.</rights><rights>Copyright © 2022 Sumalatha Mahankali et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Sumalatha Mahankali et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-89347d29127c6905ac65b3ec37e0b9551c668c032f1569805ec896e441565e363</citedby><cites>FETCH-LOGICAL-c378t-89347d29127c6905ac65b3ec37e0b9551c668c032f1569805ec896e441565e363</cites><orcidid>0000-0001-7027-4822 ; 0000-0003-1101-6051 ; 0000-0003-2708-9714 ; 0000-0003-4074-3485</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110154/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110154/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35586686$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Roy, Arpita</contributor><contributor>Arpita Roy</contributor><creatorcontrib>Mahankali, Sumalatha</creatorcontrib><creatorcontrib>Kalava, Jagadish</creatorcontrib><creatorcontrib>Garapati, Yugandhar</creatorcontrib><creatorcontrib>Domathoti, Bullarao</creatorcontrib><creatorcontrib>Maddumala, Venkata rao</creatorcontrib><creatorcontrib>Sundramurty, Venkatesa Prabhu</creatorcontrib><title>A Treatment to Cure Diabetes Using Plant-Based Drug Discovery</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>The field of peptides and proteins has opened up new doors for plant-based medication development because of analytical breakthroughs. Enzymatic breakdown of plant-specific proteins yields bioactive peptides. These plant-based proteins and peptides, in addition to their in vitro and vivo outcomes for diabetes treatment, are discussed in this study. The secondary metabolites of vegetation can interfere with the extraction, separation, characterization, and commercialization of plant proteins through the pharmaceutical industry. Glucose-lowering diabetic peptides are a hot commodity. For a wide range of illnesses, bioactive peptides from flora can offer up new avenues for the development of cost-effective therapy options.</description><subject>Amino acids</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Disease</subject><subject>Drug development</subject><subject>Hypertension</subject><subject>Insulin resistance</subject><subject>Metabolites</subject><subject>Peptides</subject><subject>Pharmaceutical industry</subject><subject>Proteins</subject><subject>Secondary metabolites</subject><subject>Seeds</subject><subject>Signal transduction</subject><subject>Sports injuries</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU1LAzEYhIMoVqs3z7LgRdC1SXbzdVCorV9Q0EML3kI2fdtuaXdrslvpvzeltagHT0mYh8kMg9AZwTeEMNaimNKW5JRwzvbQEREpiVMq5f7uLt4b6Nj7KcZUCSEOUSNhTHIu-RG6bUd9B6aaQ1FFVRl1agdRNzcZVOCjgc-LcfQ2M0UV3xsPw6jr6nHQvS2X4FYn6GBkZh5Ot2cTDR4f-p3nuPf69NJp92KbCFnFUiWpGFJFqLBcYWYsZ1kCQQScKcaIDWEsTuiIMK4kZmCl4pCm4ckg4UkT3W18F3U2h6ENYZ2Z6YXL58atdGly_Vsp8okel0utCMGEpcHgcmvgyo8afKXnoQPMQjMoa68p5yFY-JkF9OIPOi1rV4R6a0pwKrBKAnW9oawrvXcw2oUhWK930etd9HaXgJ__LLCDv4cIwNUGmOTF0Hzm_9t9AV4Rklw</recordid><startdate>20220509</startdate><enddate>20220509</enddate><creator>Mahankali, Sumalatha</creator><creator>Kalava, Jagadish</creator><creator>Garapati, Yugandhar</creator><creator>Domathoti, Bullarao</creator><creator>Maddumala, Venkata rao</creator><creator>Sundramurty, Venkatesa Prabhu</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7027-4822</orcidid><orcidid>https://orcid.org/0000-0003-1101-6051</orcidid><orcidid>https://orcid.org/0000-0003-2708-9714</orcidid><orcidid>https://orcid.org/0000-0003-4074-3485</orcidid></search><sort><creationdate>20220509</creationdate><title>A Treatment to Cure Diabetes Using Plant-Based Drug Discovery</title><author>Mahankali, Sumalatha ; Kalava, Jagadish ; Garapati, Yugandhar ; Domathoti, Bullarao ; Maddumala, Venkata rao ; Sundramurty, Venkatesa Prabhu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-89347d29127c6905ac65b3ec37e0b9551c668c032f1569805ec896e441565e363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amino acids</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Disease</topic><topic>Drug development</topic><topic>Hypertension</topic><topic>Insulin resistance</topic><topic>Metabolites</topic><topic>Peptides</topic><topic>Pharmaceutical industry</topic><topic>Proteins</topic><topic>Secondary metabolites</topic><topic>Seeds</topic><topic>Signal transduction</topic><topic>Sports injuries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahankali, Sumalatha</creatorcontrib><creatorcontrib>Kalava, Jagadish</creatorcontrib><creatorcontrib>Garapati, Yugandhar</creatorcontrib><creatorcontrib>Domathoti, Bullarao</creatorcontrib><creatorcontrib>Maddumala, Venkata rao</creatorcontrib><creatorcontrib>Sundramurty, Venkatesa Prabhu</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahankali, Sumalatha</au><au>Kalava, Jagadish</au><au>Garapati, Yugandhar</au><au>Domathoti, Bullarao</au><au>Maddumala, Venkata rao</au><au>Sundramurty, Venkatesa Prabhu</au><au>Roy, Arpita</au><au>Arpita Roy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Treatment to Cure Diabetes Using Plant-Based Drug Discovery</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2022-05-09</date><risdate>2022</risdate><volume>2022</volume><spage>8621665</spage><epage>12</epage><pages>8621665-12</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>The field of peptides and proteins has opened up new doors for plant-based medication development because of analytical breakthroughs. Enzymatic breakdown of plant-specific proteins yields bioactive peptides. These plant-based proteins and peptides, in addition to their in vitro and vivo outcomes for diabetes treatment, are discussed in this study. The secondary metabolites of vegetation can interfere with the extraction, separation, characterization, and commercialization of plant proteins through the pharmaceutical industry. Glucose-lowering diabetic peptides are a hot commodity. For a wide range of illnesses, bioactive peptides from flora can offer up new avenues for the development of cost-effective therapy options.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>35586686</pmid><doi>10.1155/2022/8621665</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7027-4822</orcidid><orcidid>https://orcid.org/0000-0003-1101-6051</orcidid><orcidid>https://orcid.org/0000-0003-2708-9714</orcidid><orcidid>https://orcid.org/0000-0003-4074-3485</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1741-427X |
| ispartof | Evidence-based complementary and alternative medicine, 2022-05, Vol.2022, p.8621665-12 |
| issn | 1741-427X 1741-4288 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9110154 |
| source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
| subjects | Amino acids Diabetes Diabetes mellitus Disease Drug development Hypertension Insulin resistance Metabolites Peptides Pharmaceutical industry Proteins Secondary metabolites Seeds Signal transduction Sports injuries |
| title | A Treatment to Cure Diabetes Using Plant-Based Drug Discovery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A41%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Treatment%20to%20Cure%20Diabetes%20Using%20Plant-Based%20Drug%20Discovery&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Mahankali,%20Sumalatha&rft.date=2022-05-09&rft.volume=2022&rft.spage=8621665&rft.epage=12&rft.pages=8621665-12&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2022/8621665&rft_dat=%3Cproquest_pubme%3E2666908055%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2667627093&rft_id=info:pmid/35586686&rfr_iscdi=true |